{"id":220364,"date":"2026-08-27T09:46:12","date_gmt":"2026-08-27T04:16:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=220364"},"modified":"2026-08-27T09:46:12","modified_gmt":"2026-08-27T04:16:12","slug":"why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/","title":{"rendered":"Glenmark Pharmaceuticals Ltd. (GLENMARK): Glenmark Pharmaceuticals Share Price hits fresh 52-week high"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals Ltd. (GLENMARK)<\/a> share price reached a fresh 52-week high of Rs 2,483.3 today and later stood at Rs 2,468, up 1.15% from the previous close. Market cap was Rs 67,592.81 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 27 August 2026 at 9:29 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Glenmark Pharmaceuticals Share Price is in focus after the stock rose to Rs 2,468, up 1.15% today, and touched a fresh 52-week high of Rs 2,483.30. The company\u2019s market capitalisation stands at Rs 67,592.81 crore, placing GLENMARK among the notable names in the healthcare pack on NSE and BSE. Univest notes that the price event is verified by the day\u2019s data, while the supplied information does not establish a company-specific catalyst for the move.<\/p>\n<p>The session opened at Rs 2,440, matched the day\u2019s low at Rs 2,440 and went on to mark the high at Rs 2,483.30 before settling at Rs 2,468. The day change of Rs 28 reflects the move against the previous close of Rs 2,440. For readers tracking Glenmark Pharmaceuticals Share Price Today, the event is relevant because the stock has now printed a fresh yearly high while also remaining within a clear market-cap and valuation discussion on Univest.<\/p>\n<p>For investors searching Glenmark Pharmaceuticals Stock News, the immediate takeaway is factual: price moved higher, the fresh 52-week high was set, and the latest valuation metrics remain visible in the supplied data. Univest will continue to frame this as a price event first, then place the move in context through fundamentals, sector benchmarks and peer comparison. The numbers point to a stock that is drawing attention in the Indian stock market, but the supplied data alone does not identify a specific trigger.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Glenmark_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\" title=\"Glenmark Pharmaceuticals Share Price Today: Price Action Analysis\">Glenmark Pharmaceuticals Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Glenmark_Pharmaceuticals_Ltd_GLENMARK_Fundamental_Analysis\" title=\"Glenmark Pharmaceuticals Ltd. (GLENMARK) Fundamental Analysis\">Glenmark Pharmaceuticals Ltd. (GLENMARK) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Why_Investors_Are_Watching_Glenmark_Pharmaceuticals\" title=\"Why Investors Are Watching Glenmark Pharmaceuticals\">Why Investors Are Watching Glenmark Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#About_Glenmark_Pharmaceuticals\" title=\"About Glenmark Pharmaceuticals\">About Glenmark Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Track_Glenmark_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Glenmark Pharmaceuticals Share Price on Univest\">Track Glenmark Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Why_is_Glenmark_Pharmaceuticals_Share_Price_in_news_today\" title=\"Why is Glenmark Pharmaceuticals Share Price in news today?\">Why is Glenmark Pharmaceuticals Share Price in news today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#What_is_the_current_Glenmark_Pharmaceuticals_Share_Price\" title=\"What is the current Glenmark Pharmaceuticals Share Price?\">What is the current Glenmark Pharmaceuticals Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#What_is_Glenmark_Pharmaceuticals_52-week_high\" title=\"What is Glenmark Pharmaceuticals 52-week high?\">What is Glenmark Pharmaceuticals 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#What_is_Glenmark_Pharmaceuticals_market_capitalisation\" title=\"What is Glenmark Pharmaceuticals market capitalisation?\">What is Glenmark Pharmaceuticals market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#How_does_Glenmark_Pharmaceuticals_trade_on_valuation\" title=\"How does Glenmark Pharmaceuticals trade on valuation?\">How does Glenmark Pharmaceuticals trade on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#What_do_Glenmark_Pharmaceuticals_EPS_and_book_value_show\" title=\"What do Glenmark Pharmaceuticals EPS and book value show?\">What do Glenmark Pharmaceuticals EPS and book value show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#How_do_Glenmark_Pharmaceuticals_ROE_and_ROCE_compare\" title=\"How do Glenmark Pharmaceuticals ROE and ROCE compare?\">How do Glenmark Pharmaceuticals ROE and ROCE compare?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glenmark Pharmaceuticals Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,468<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,440<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 28 (+1.15%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,440<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,483.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,440<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.19 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67,592.81 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Pharmaceuticals Ltd. (GLENMARK) traded at Rs 2,468 versus the previous close of Rs 2,440, a rise of 1.15%. The stock opened at Rs 2,440, reached a high of Rs 2,483.3 and touched a low of Rs 2,440.<\/p>\n<p>Glenmark Pharmaceuticals Share Price Today shows a straightforward upward move. The stock closed the prior session at Rs 2,440 and added Rs 28 to finish at Rs 2,468, a gain of 1.15%. It opened at Rs 2,440, traded between Rs 2,440 and Rs 2,483.30, and matched that upper end with the fresh 52-week high. Turnover stood at Rs 1.19 crore, which gives a factual sense of the day\u2019s traded value without adding any interpretation beyond the supplied numbers.<\/p>\n<p>The fresh 52-week high is important because it marks a yearly high for GLENMARK rather than an all-time high. On a simple arithmetic basis, the stock\u2019s high of Rs 2,483.30 is above the previous close by Rs 43.30, or about 1.77%. That difference is useful for readers scanning Glenmark Pharmaceuticals Share Price Live and Glenmark Pharmaceuticals Share Price Update pages on Univest. The data confirms the day\u2019s price event clearly, but it does not by itself explain a company-specific reason behind the move.<\/p>\n<p>From a news perspective, Glenmark Pharmaceuticals Share News and Glenmark Pharmaceuticals Latest News searches are likely to focus on this fresh 52-week high because it is the day\u2019s verified headline fact. For stock market today readers, the point is not to infer a narrative from the move, but to note that the stock printed a new one-year high while closing above the previous session\u2019s level. That is the clearest factual summary available from the supplied data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Pharmaceuticals_Ltd_GLENMARK_Fundamental_Analysis\"><\/span><strong>Glenmark Pharmaceuticals Ltd. (GLENMARK) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67,592.81 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 388.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.1%<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Pharmaceuticals Ltd. (GLENMARK) fundamental metrics show P\/E 38.3x, P\/B 6.28x, ROE 14.1%, ROCE 20.35%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Glenmark Pharmaceuticals Ltd. has a market capitalisation of Rs 67592.81 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 38.3x, P\/B at 6.28x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.1% and ROCE of 20.35%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.7, book value per share of Rs 388.43, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 30.54x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.19x to 671.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.75%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67,592.81 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 623.8 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Pharmaceuticals Ltd. (GLENMARK) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Glenmark Pharmaceuticals Ltd. (GLENMARK) has a P\/E ratio of 38.3x, which is above the benchmark median of 30.54x, a difference of +25.41%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Glenmark Pharmaceuticals Ltd. (GLENMARK) has a ROE of 14.1%, which is above the benchmark median of 11.83%, a difference of +19.19%. Glenmark Pharmaceuticals Ltd. (GLENMARK) has a ROCE of 20.35%, which is above the benchmark median of 13.75%, a difference of +48%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Biocon Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BIOCON<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">67,567.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">137.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Alkem Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALKEM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">63,931.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.28<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Abbott India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ABBOTINDIA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">56,173.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.72<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glaxosmithkline Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAXO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">50,483.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">66.79<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/auropharma\/aurobindo-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aurobindo Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AUROPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">92,247.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.76<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Pharmaceuticals Ltd. (GLENMARK) has a P\/E ratio of 38.3x compared with the displayed peer median of 34.88x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.1% compares with a peer median of 18.29% across the companies shown in the table. ROCE stood at 20.35% versus the displayed peer median of 21.28%, providing a capital-efficiency comparison. Glenmark Pharmaceuticals Ltd. (GLENMARK) has a market capitalisation of Rs 67,592.81 crore. Among the 5 peers shown, 1 has a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glenmark_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Glenmark Pharmaceuticals Share Price hit a fresh 52-week high of Rs 2,483.30 and closed at Rs 2,468.<\/li>\n<li>The stock rose 1.15% today from the previous close of Rs 2,440.<\/li>\n<li>Market capitalisation stands at Rs 67,592.81 crore, with P\/E at 38.3 and P\/B at 6.28.<\/li>\n<li>ROE is 14.1% and ROCE is 20.35%, both above the same-industry benchmark median.<\/li>\n<li>Revenue for Jun-26 was Rs 40,184.83 crore and net profit was Rs 4,829.24 crore.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glenmark_Pharmaceuticals\"><\/span><strong>About Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glenmark Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied data also places it within the same-industry comparison set used in this Glenmark Pharmaceuticals Stock Analysis. For readers following Glenmark Pharmaceuticals Share Price and Glenmark Pharmaceuticals Company News, this classification is the core business context available in the dataset.<\/p>\n<p>The company\u2019s reported financial indicators include revenue, net profit, EPS, book value and return ratios, which together give a basic company overview for Univest readers. That keeps Glenmark Pharmaceuticals Fundamental Analysis anchored to verified information rather than broad industry assumptions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Glenmark_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Glenmark Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals Ltd. (GLENMARK) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Track Glenmark Pharmaceuticals Share Price on Univest for live share price updates, Glenmark Pharmaceuticals Share Price Today, sector context, valuation ratios, 52-week levels, shareholding pattern and company financials. Univest brings the key stock news, market cap and peer comparison together in one place for easier review.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Glenmark_Pharmaceuticals_Share_Price_in_news_today\"><\/span><strong>Why is Glenmark Pharmaceuticals Share Price in news today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Pharmaceuticals Share Price is in news because it touched a fresh 52-week high of Rs 2,483.30 and closed at Rs 2,468. The move also keeps the stock in focus for Glenmark Pharmaceuticals Stock News readers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_Glenmark_Pharmaceuticals_Share_Price\"><\/span><strong>What is the current Glenmark Pharmaceuticals Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current Glenmark Pharmaceuticals Share Price is Rs 2,468. It is up 1.15% from the previous close of Rs 2,440, with the session high matching the fresh 52-week high of Rs 2,483.30.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glenmark_Pharmaceuticals_52-week_high\"><\/span><strong>What is Glenmark Pharmaceuticals 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Pharmaceuticals 52-week high is Rs 2,483.30. The stock reached that level during the session, making it a fresh yearly high rather than an all-time high. The stock moved 1.15% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glenmark_Pharmaceuticals_market_capitalisation\"><\/span><strong>What is Glenmark Pharmaceuticals market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Pharmaceuticals has a market capitalisation of Rs 67,592.81 crore. That places the company well above the same-industry median market cap shown in the supplied healthcare benchmark. The company operates in the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Pharmaceuticals_trade_on_valuation\"><\/span><strong>How does Glenmark Pharmaceuticals trade on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Pharmaceuticals trades at a P\/E of 38.3 and a P\/B of 6.28. In the supplied industry benchmark, both sit above the median, while ROE and ROCE also stand above the benchmark median.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Glenmark_Pharmaceuticals_EPS_and_book_value_show\"><\/span><strong>What do Glenmark Pharmaceuticals EPS and book value show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Pharmaceuticals reports EPS of 63.7 and book value of Rs 388.43. EPS reflects earnings per share, while book value shows accounting net worth per share, both useful in share price analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_Glenmark_Pharmaceuticals_ROE_and_ROCE_compare\"><\/span><strong>How do Glenmark Pharmaceuticals ROE and ROCE compare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Pharmaceuticals reports ROE of 14.1% and ROCE of 20.35%. Both are above the same-industry benchmark median in the supplied data, which gives useful context for Glenmark Pharmaceuticals Stock Analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals Ltd. Share Price hits a new 52-week high at Rs 2,468. marking a 1.15% rise today. Market cap stands at Rs 67,592.81 crore.<\/p>\n","protected":false},"author":29,"featured_media":220363,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-220364","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["220363"],"rank_math_title":["Glenmark Pharmaceuticals Share Price hits fresh 52-week high"],"rank_math_description":["Glenmark Pharmaceuticals Share Price hits a fresh 52-week high at Rs 2,483.30. See today\u2019s move, valuation, peers and sector context."],"rank_math_focus_keyword":["Glenmark Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Glenmark_Pharmaceuticals_Ltd_GLENMARK_Glenmark_Pharmaceuticals_Share_Price_hits_fresh_52_week_high_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/220364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=220364"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/220364\/revisions"}],"predecessor-version":[{"id":220365,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/220364\/revisions\/220365"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/220363"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=220364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=220364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=220364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}